TFA
Toth Financial Advisory’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,332
| Closed | -$38.1K | – | 757 |
|
|
2024
Q2 | $38.1K | Hold |
1,332
| – | – | ﹤0.01% | 318 |
|
|
2024
Q1 | $38.9K | Sell |
1,332
-10
| -0.7% | -$292 | ﹤0.01% | 314 |
|
|
2023
Q4 | $45.3K | Sell |
1,342
-355
| -21% | -$12K | 0.01% | 305 |
|
|
2023
Q3 | $52.1K | Hold |
1,697
| – | – | 0.01% | 265 |
|
|
2023
Q2 | $68K | Hold |
1,697
| – | – | 0.01% | 244 |
|
|
2023
Q1 | $69.3K | Hold |
1,697
| – | – | 0.01% | 250 |
|
|
2022
Q4 | $65.5K | Sell |
1,697
-125
| -7% | -$4.83K | 0.01% | 257 |
|
|
2022
Q3 | $97K | Hold |
1,822
| – | – | 0.02% | 216 |
|
|
2022
Q2 | $106K | Sell |
1,822
-11,550
| -86% | -$672K | 0.02% | 213 |
|
|
2022
Q1 | $1.02M | Buy |
13,372
+12,239
| +1,080% | +$934K | 0.15% | 115 |
|
|
2021
Q4 | $68K | Hold |
1,133
| – | – | 0.01% | 272 |
|
|
2021
Q3 | $63K | Hold |
1,133
| – | – | 0.01% | 283 |
|
|
2021
Q2 | $69K | Sell |
1,133
-17,715
| -94% | -$1.08M | 0.01% | 253 |
|
|
2021
Q1 | $1.32M | Buy |
18,848
+1,228
| +7% | +$86.1K | 0.21% | 92 |
|
|
2020
Q4 | $1.05M | Buy |
17,620
+2,855
| +19% | +$171K | 0.18% | 99 |
|
|
2020
Q3 | $888K | Buy |
14,765
+25
| +0.2% | +$1.5K | 0.17% | 102 |
|
|
2020
Q2 | $773K | Buy |
14,740
+12,890
| +697% | +$676K | 0.17% | 100 |
|
|
2020
Q1 | $62K | Buy |
+1,850
| New | +$62K | 0.02% | 167 |
|